Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia

Nature Communications

Volumn 5, Issue , 2014, Pages

  Fieblinger, Tim ^a   Graves, Steven M ^b   Sebel, Luke E ^b   Alcacer, Cristina ^a   Plotkin, Joshua L ^b   Gertler, Tracy S ^b   Chan, C Savio ^b   Heiman, Myriam ^c   Greengard, Paul ^d   Cenci, M Angela ^a   Surmeier, D James ^b  

^a LUND UNIVERSITY   (Sweden)

^b NORTHWESTERN UNIVERSITY   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA; AMPA RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

CONNECTIVITY; MODEL VALIDATION; NERVOUS SYSTEM DISORDER; NEUROLOGY; PATHOLOGY;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DYSKINESIA; HOMEOSTASIS; MALE; MOUSE; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NERVE PROJECTION; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; ANIMAL; C57BL MOUSE; DENDRITIC SPINE; DISEASE MODEL; DOPAMINERGIC NERVE CELL; IN VITRO STUDY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CORPUS STRIATUM; DENDRITIC SPINES; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; DYSKINESIA, DRUG-INDUCED; IN VITRO TECHNIQUES; MALE; MICE, INBRED C57BL; NEURONAL PLASTICITY; PARKINSONIAN DISORDERS; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84920795588     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6316     Document Type: Article

References (67)

1. Redgrave, P. et al. Goal-directed and habitual control in the basal ganglia: Implications for Parkinson's disease. Nat. Rev. Neurosci. 11, 760-772 (2010).
2. Gerfen, C. R. & Surmeier, D. J. Modulation of striatal projection systems by dopamine. Annu. Rev. Neurosci. 34, 441-466 (2011).
3. Freeze, B. S., Kravitz, A. V., Hammack, N., Berke, J. D. & Kreitzer, A. C. Control of basal ganglia output by direct and indirect pathway projection neurons. J. Neurosci. 33, 18531-18539 (2013).
4. Surmeier, D. J., Ding, J., Day, M., Wang, Z. & Shen, W. D1 and D2 dopaminereceptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci. 30, 228-235 (2007).
5. Hornykiewicz, O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol. Rev. 18, 925-964 (1966).
6. Shen, W., Flajolet, M., Greengard, P. & Surmeier, D. J. Dichotomous dopaminergic control of striatal synaptic plasticity. Science 321, 848-851 (2008).
7. Albin, R. L., Young, A. B. & Penney, J. B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366-375 (1989).
8. Cenci, M. A. & Lindgren, H. S. Advances in understanding L-DOPA-induced dyskinesia. Curr. Opin. Neurobiol. 17, 665-671 (2007).
9. Cenci, M. A. & Lundblad, M. Post-versus presynaptic plasticity in L-DOPA-induced dyskinesia. J. Neurochem. 99, 381-392 (2006).
10. Cenci, M. A. Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia. Trends Neurosci. 30, 236-243 (2007).
11. De La Fuente-Fernandez, R. et al. Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: Implications for dyskinesias. Brain 127, 2747-2754 (2004).
12. Barroso-Chinea, P. & Bezard, E. Basal ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia. Front. Neuroanat. 4 (2010).
13. Murer, M. G. & Moratalla, R. Striatal signaling in L-DOPA-induced dyskinesia: Common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation. Front. Neuroanat. 5, 51 (2011).
14. Turrigiano, G. Homeostatic synaptic plasticity: Local and global mechanisms for stabilizing neuronal function. Cold Spring Harb. Perspect. Biol. 4, a005736 (2012).
15. Turrigiano, G. G. Homeostatic plasticity in neuronal networks: The more things change, the more they stay the same. Trends Neurosci. 22, 221-227 (1999).
16. Day, M. et al. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat. Neurosci. 9, 251-259 (2006).
17. Cenci, M. A. & Konradi, C. Maladaptive striatal plasticity in L-DOPA-induced dyskinesia. Prog. Brain Res. 183, 209-233 (2010).
18. Heiman, M. et al. Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia. Proc. Natl Acad. Sci. USA 111, 4578-4583 (2014).
19. Westin, J. E., Vercammen, L., Strome, E. M., Konradi, C. & Cenci, M. A. Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors. Biol. Psychiatry 62, 800-810 (2007).
20. Zhang, Y. et al. Aberrant restoration of spines and their synapses in L-DOPAinduced dyskinesia: Involvement of corticostriatal but not thalamostriatal synapses. J. Neurosci. 33, 11655-11667 (2013).
21. Suarez, L. M. et al. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice. Biol. Psychiatry 75, 711-722 (2013).
22. Nishijima, H. et al. Morphologic changes of dendritic spines of striatal neurons in the levodopa-induced dyskinesia model. Mov. Disord. 29(Suppl 3): 336-343 (2014).
23. Gertler, T. S., Chan, C. S. & Surmeier, D. J. Dichotomous anatomical properties of adult striatal medium spiny neurons. J. Neurosci. 28, 10814-10824 (2008).
24. Kreitzer, A. C. & Malenka, R. C. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature 445, 643-647 (2007).
25. Day, M., Wokosin, D., Plotkin, J. L., Tian, X. & Surmeier, D. J. Differential excitability and modulation of striatal medium spiny neuron dendrites. J. Neurosci. 28, 11603-11614 (2008).
26. Chan, C. S. et al. Strain-specific regulation of striatal phenotype in Drd2-eGFP BAC transgenic mice. J. Neurosci. 32, 9124-9132 (2012).
27. Carter, A. G. & Sabatini, B. L. State-dependent calcium signaling in dendritic spines of striatal medium spiny neurons. Neuron 44, 483-493 (2004).
28. Bolam, J. P., Hanley, J. J., Booth, P. A. & Bevan, M. D. Synaptic organisation of the basal ganglia. J. Anat. 196(Pt 4): 527-542 (2000).
29. Smith, Y. et al. The thalamostriatal systems: Anatomical and functional organization in normal and parkinsonian states. Brain Res. Bull. 78, 60-68 (2009).
30. Arenkiel, B. R. et al. In vivo light-induced activation of neural circuitry in transgenic mice expressing channelrhodopsin-2. Neuron 54, 205-218 (2007).
31. Plotkin, J. L. et al. Impaired TrkB receptor signaling underlies corticostriatal dysfunction in huntington's disease. Neuron 83, 178-188 (2014).
32. Petreanu, L., Mao, T., Sternson, S. M. & Svoboda, K. The subcellular organization of neocortical excitatory connections. Nature 457, 1142-1145 (2009).
33. Villalba, R. M. & Smith, Y. Differential structural plasticity of corticostriatal and thalamostriatal axo-spinous synapses in MPTP-treated Parkinsonian monkeys. J. Comp. Neurol. 519, 989-1005 (2011).
34. Peterson, J. D., Goldberg, J. A. & Surmeier, D. J. Adenosine A2a receptor antagonists attenuate striatal adaptations following dopamine depletion. Neurobiol. Dis. 45, 409-416 (2012).
35. Kreitzer, A. C. & Malenka, R. C. Striatal plasticity and basal ganglia circuit function. Neuron 60, 543-554 (2008).
36. Wall, N. R., De La Parra, M., Callaway, E. M. & Kreitzer, A. C. Differential innervation of direct-and indirect-pathway striatal projection neurons. Neuron 79, 347-360 (2013).
37. Gardoni, F. et al. A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. J. Neurosci. 26, 2914-2922 (2006).
38. Ding, J., Peterson, J. D. & Surmeier, D. J. Corticostriatal and thalamostriatal synapses have distinctive properties. J. Neurosci. 28, 6483-6492 (2008).
39. McNeill, T. H., Brown, S. A., Rafols, J. A. & Shoulson, I. Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease. Brain Res. 455, 148-152 (1988).
40. Zaja-Milatovic, S. et al. Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology 64, 545-547 (2005).
41. Seroogy, K. B. et al. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J. Comp. Neurol. 342, 321-334 (1994).
42. Baquet, Z. C., Bickford, P. C. & Jones, K. R. Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta. J. Neurosci. 25, 6251-6259 (2005).
43. Jan, Y. N. & Jan, L. Y. Branching out: Mechanisms of dendritic arborization. Nat. Rev. Neurosci. 11, 316-328 (2010).
44. Dunah, A. W. & Standaert, D. G. Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. J. Neurosci. 21, 5546-5558 (2001).
45. Hallett, P. J. et al. Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease. Neuropharmacology 48, 503-516 (2005).
46. Lai, S. K. et al. Gene expression of glutamate receptors GluR1 and NR1 is differentially modulated in striatal neurons in rats after 6-hydroxydopamine lesion. Neurochem. Int. 43, 639-653 (2003).
47. Toy, W. A. et al. Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. Neurobiol. Dis. 63, 201-209 (2014).
48. Villalba, R. M., Wichmann, T. & Smith, Y. Neuronal loss in the caudal intralaminar thalamic nuclei in a primate model of Parkinson's disease. Brain Struct. Funct. 219, 381-394 (2014).
49. Cicchetti, F. et al. Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur. J. Neurosci. 15, 991-998 (2002).
50. Francardo, V. et al. Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism. Brain 137, 1998-2014 (2014).
51. Fasano, C. et al. Dopamine facilitates dendritic spine formation by cultured striatal medium spiny neurons through both D1 and D2 dopamine receptors. Neuropharmacology 67, 432-443 (2013).
52. Mallet, N., Le Moine, C., Charpier, S. & Gonon, F. Feedforward inhibition of projection neurons by fast-spiking GABA interneurons in the rat striatum in vivo. J. Neurosci. 25, 3857-3869 (2005).
53. Mallet, N., Ballion, B., Le Moine, C. & Gonon, F. Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of parkinsonian rats. J. Neurosci. 26, 3875-3884 (2006).
54. Zigmond, M. J. Do compensatory processes underlie the preclinical phase of neurodegenerative disease? Insights from an animal model of parkinsonism. Neurobiol. Dis. 4, 247-253 (1997).
55. Bezard, E., Gross, C. E. & Brotchie, J. M. Presymptomatic compensation in Parkinson's disease is not dopamine-mediated. Trends Neurosci. 26, 215-221 (2003).
56. Turrigiano, G. G. The self-tuning neuron: Synaptic scaling of excitatory synapses. Cell 135, 422-435 (2008).
57. Vitureira, N. & Goda, Y. Cell biology in neuroscience: The interplay between Hebbian and homeostatic synaptic plasticity. J. Cell Biol. 203, 175-186 (2013).
58. Picconi, B. et al. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat. Neurosci. 6, 501-506 (2003).
59. + channels is dependent on a Shank-binding domain. J. Neurosci. 25, 1050-1062 (2005).
60. Hardingham, G. E. & Bading, H. Synaptic versus extrasynaptic NMDA receptor signalling: Implications for neurodegenerative disorders. Nat. Rev. Neurosci. 11, 682-696 (2010).
61. Zold, C. L., Ballion, B., Riquelme, L. A., Gonon, F. & Murer, M. G. Nigrostriatal lesion induces D2-modulated phase-locked activity in the basal ganglia of rats. Eur. J. Neurosci. 25, 2131-2144 (2007).
62. Ballion, B. et al. D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism. Neurobiol. Dis. 35, 376-384 (2009).
63. Matsuda, W. et al. Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J. Neurosci. 29, 444-453 (2009).
64. Francardo, V. et al. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease. Neurobiol. Dis. 42, 327-340 (2011).
65. Cenci, M. A. & Lundblad, M. Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice. Curr. Protoc. Neurosci. Chapter 9, Unit 9.25 (2007).
66. Lundblad, M., Picconi, B., Lindgren, H. & Cenci, M. A. A model of L-DOPAinduced dyskinesia in 6-hydroxydopamine lesioned mice: Relation to motor and cellular parameters of nigrostriatal function. Neurobiol. Dis. 16, 110-123 (2004).
67. Plotkin, J. L., Day, M. & Surmeier, D. J. Synaptically driven state transitions in distal dendrites of striatal spiny neurons. Nat. Neurosci. 14, 881-888 (2011).